SCHEMBL23409104

SCHEMBL23409104

COc1ccc(Cl)cc1C(=O)c1cccc(C)c1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.56
NPC1 O15118 2/20 0.52
RAB9A P51151 2/20 0.52
KCNMA1 Q12791 1/20 0.52
MAPT P10636 6/20 0.51
LMNA P02545 2/20 0.51
HTT P42858 2/20 0.51
NPSR1 Q6W5P4 2/20 0.51
HPGD P15428 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
CTNNB1 P35222 1/20 0.51
WNT3A P56704 1/20 0.51
KDM4E B2RXH2 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
THRB P10828 1/20 0.49
KCNK3 O14649 2/20 0.48
KCNK9 Q9NPC2 2/20 0.48
PKM P14618 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6103175 0.85 POLB (0.66) POLBMAPTLMNAHTTNPSR1
SCHEMBL14419573 0.84 POLB (0.57) POLBRAB9AKCNMA1MAPTLMNA
SCHEMBL3143842 0.83 POLB (0.57) POLBNPC1RAB9AMAPTLMNA
SCHEMBL7635082 0.83 STAT3 (0.62) POLBNPC1RAB9AMAPTHPGD
SCHEMBL14419292 0.83 PTGDR2 (0.56) POLBMAPTLMNAHTTNPSR1
SCHEMBL25068874 0.82 POLB (0.52) POLBKCNMA1MAPTLMNAHTT
SCHEMBL23409105 0.82 LMNA (0.52) POLBMAPTLMNAHPGDSMN1; SMN2
SCHEMBL6940233 0.82 SMN1; SMN2 (0.56) POLBNPC1RAB9AMAPTLMNA
SCHEMBL8809386 0.82 RAB9A (0.69) POLBNPC1RAB9AKCNMA1CTNNB1
SCHEMBL24460136 0.81 LOXL2 (0.52) POLBMAPTLMNAHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230055961-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF DUNAD THERAPEUTICS LTD. (GB) 2023-02-23 US disclosed
WO-2022106897-A2 METHODS AND COMPOSITION FOR KRAS MODIFICATIONS 2692372 ONTARIO, INC. (CA) 2022-05-27 WO disclosed
WO-2021099842-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO INC. (CA) 2021-05-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055961-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF FURIN, PFAS, CFTR POLB 2024/4885NPC1 296/4885RAB9A 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.